SCHEMBL7602644

SCHEMBL7602644

O=C(OCCCc1ccccc1)C1=C(COCCN2CCCCC2)NC(c2ccco2)=NC1c1ccc(Cl)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.35
▸ SLC6A4 P31645 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CACNA1F O60840 2/20 0.33
▸ CACNA1D Q01668 2/20 0.33
▸ CACNA1S Q13698 2/20 0.33
▸ CACNA1C Q13936 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CHRNB4 P30926 2/20 0.33
▸ CHRNA3 P32297 2/20 0.33
▸ CHRNB2 P17787 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ BCHE P06276 4/20 0.32
▸ GPBAR1 Q8TDU6 1/20 0.32
▸ MCHR1 Q99705 1/20 0.32
▸ HTR4 Q13639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914608 0.94 HRH3 (0.36) HRH3ALDH1A1SMN1; SMN2CHRNB4CHRNA3
SCHEMBL7913694 0.94 HRH3 (0.36) HRH3SLC6A4ALDH1A1SMN1; SMN2CACNA1F
SCHEMBL7535010 0.90 ADRA1A (0.37) HRH3SLC6A4ALDH1A1SMN1; SMN2CACNA1F
SCHEMBL7916689 0.89 HRH3 (0.36) HRH3ALDH1A1SMN1; SMN2CACNA1FCACNA1D
SCHEMBL7418138 0.88 SIGMAR1 (0.36) HRH3ALDH1A1BCHEGPBAR1
SCHEMBL7916244 0.87 NPC1 (0.44) HRH3ALDH1A1SMN1; SMN2CACNA1FCACNA1D
SCHEMBL7914613 0.86 HTR1A (0.40) HRH3ALDH1A1SMN1; SMN2CACNA1FCACNA1D
SCHEMBL7422291 0.85 HRH3 (0.34) HRH3SLC6A4ALDH1A1SMN1; SMN2BCHE
SCHEMBL7906593 0.85 HRH3 (0.34) HRH3SLC6A4ALDH1A1SMN1; SMN2BCHE
SCHEMBL7906535 0.85 ALDH1A1 (0.37) HRH3SLC6A4ALDH1A1SMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218538-B1 ANTAGONISTS OF N-TYPE NEURONAL CALCIUM CHANNELS USEFUL IN THE TREATMENT OF CEREBROVASCULAR ISCHAEMIA AND PAIN. ASTRA AKTIEBOLAG (SE) 2001-04-17 — — US claimed
US-6218538-B1 ANTAGONISTS OF N-TYPE NEURONAL CALCIUM CHANNELS USEFUL IN THE TREATMENT OF CEREBROVASCULAR ISCHAEMIA AND PAIN. ASTRA AKTIEBOLAG (SE) 2001-04-17 — — US disclosed
EP-0993450-A1 NEW COMPOUNDS Astra Aktiebolag (publ) (SE) 2000-04-19 — — EP disclosed
WO-1999001438-A1 NEW COMPOUNDS ASTRA AKTIEBOLAG (PUBL) (SE) 1999-01-14 — — WO disclosed
Send feedback